CYNAPSUS THERAPEUTICS INC. (A corporation incorporated under the Canada Business Corporations Act) [ — ] Common Shares UNDERWRITING AGREEMENTUnderwriting Agreement • June 17th, 2015 • Cynapsus Therapeutics Inc. • Pharmaceutical preparations • New York
The undersigned, a holder of Common Shares[ and an officer and/or director ]of Cynapsus Therapeutics Inc., a corporation organized under the laws of Canada (the “Company”), understands that Merrill Lynch, Pierce, Fenner & Smith Incorporated (“Merrill Lynch”) proposes to enter into an Underwriting Agreement (the “Underwriting Agreement”) with the Company providing for the public offering (the “Public Offering”) of its common shares (the “Common Shares,” and the Common Shares to be offered pursuant to the Underwriting Agreement, the “Securities”). In recognition of the benefit that such an offering will confer upon the undersigned as a holder of Common Shares[ and an officer and/or director of the Company], and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the undersigned agrees with each underwriter to be named in the Underwriting Agreement that, during the period beginning on the date hereof and ending on the date that is 90 da
